Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ali

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
The International Journal on Drug Policy|November 4, 2021
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependenceMichael Farrell, Jeyran Shahbazi, Marianne Byrne, et al.
Addiction Science & Clinical Practice|March 15, 2022
'The Drug Survey App': a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander AustraliansJames H Conigrave, Scott Wilson, Katherine M Conigrave, et al.
The American Journal of Psychiatry|September 1, 2025
Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET StudyLuke James Vano, Robert Ali McCutcheon, Jan Sedlacik, et al.
The International Journal on Drug Policy|March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trialMichael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Addiction (Abingdon, England)|December 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trialNadine Ezard, Brendan Clifford, Krista J Siefried, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
The International Journal on Drug Policy|November 4, 2021
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependenceMichael Farrell, Jeyran Shahbazi, Marianne Byrne, et al.
Addiction Science & Clinical Practice|March 15, 2022
'The Drug Survey App': a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander AustraliansJames H Conigrave, Scott Wilson, Katherine M Conigrave, et al.
The American Journal of Psychiatry|September 1, 2025
Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET StudyLuke James Vano, Robert Ali McCutcheon, Jan Sedlacik, et al.
The International Journal on Drug Policy|March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trialMichael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Addiction (Abingdon, England)|December 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trialNadine Ezard, Brendan Clifford, Krista J Siefried, et al.
Pageof 12